C67.7 Malignant neoplasm of urachus

Name of the Condition

• Malignant neoplasm of urachus
• Urachal cancer

Summary

Malignant neoplasm of the urachus refers to cancer that originates in the urachus, a remnant of the fetal umbilical cord that connects the bladder to the umbilicus. This condition involves abnormal cell growth within the urachal tissue, which can invade surrounding structures and potentially spread to other parts of the body. It is a rare form of cancer, typically arising from the epithelial lining of the urachus.

Causes

The exact cause of urachal cancer is not fully understood, but it often involves genetic mutations in urachal cells. These mutations may be triggered by chronic inflammation or exposure to carcinogens, which can damage DNA and lead to uncontrolled cell growth. The urachus, a vestigial structure, may be susceptible to such cellular changes over time.

Risk Factors

• Smoking: Tobacco use may increase risk, as carcinogens can affect nearby tissues.
• Chronic inflammation: Conditions like cystitis or bladder infections may contribute.
• Age: Most cases occur in individuals between 40 and 70.
• Gender: Males are more frequently affected than females.
• Prior bladder or urachal surgery: Surgical history may elevate risk.
• Family history: A genetic predisposition can play a role.

Symptoms

• Blood in urine (hematuria), which may be visible or detected microscopically.
• Abdominal or pelvic pain, often localized to the lower abdomen.
• A palpable mass in the lower abdomen.
• Urinary frequency or urgency.
• Discharge from the umbilicus (rare).

Diagnosis

Diagnosis typically involves imaging studies such as ultrasound, CT, or MRI to identify a mass in the urachal region. Cystoscopy may be performed to rule out bladder involvement. Biopsy of the mass, often via surgical excision, is required to confirm malignancy and determine the cancer type. Laboratory tests, including urine analysis, may also be used to assess for blood or abnormal cells.

Treatment Options

Treatment depends on the stage and extent of the cancer. Surgical removal of the urachus and surrounding tissue (partial cystectomy) is common. For advanced cases, chemotherapy or radiation therapy may be used. Targeted therapies or immunotherapy may be considered for specific subtypes. Treatment plans are tailored to the individual's overall health and cancer characteristics.

Prognosis and Follow-Up

Prognosis varies based on the cancer's stage at diagnosis and its response to treatment. Early-stage urachal cancer has a better prognosis, while advanced or metastatic disease may have a poorer outlook. Regular follow-up with imaging and clinical evaluations is essential to monitor for recurrence or progression. Long-term surveillance is recommended.

Complications

• Local invasion: The cancer may spread to nearby organs like the bladder or abdominal wall.
• Metastasis: Distant spread to lymph nodes, lungs, or bones can occur.
• Urinary obstruction: Tumors may block the bladder or urethra.
• Infection: Surgical or treatment-related complications may lead to infections.
• Recurrence: The cancer may return after initial treatment.

Lifestyle & Prevention

• Avoid smoking to reduce carcinogen exposure.
• Maintain good bladder health to minimize chronic inflammation.
• Seek prompt treatment for urinary tract infections or bladder issues.
• Follow a balanced diet and regular exercise to support overall health.
• Discuss family history with a healthcare provider for personalized risk assessment.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent blood in urine, abdominal pain, or a palpable mass. Seek immediate care for severe symptoms like uncontrolled bleeding or urinary obstruction. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for malignant neoplasm of the urachus (C67.7), ensure documentation specifies the anatomical location and confirms malignancy. Verify that the code aligns with the diagnosis and that any associated procedures or treatments are appropriately coded. Review clinical notes for details on staging, histology, or metastasis to support accurate coding.